Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles
- PMID: 20668118
- PMCID: PMC2923725
- DOI: 10.1148/radiol.10092473
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles
Abstract
Purpose: To investigate the potential of spectral computed tomography (CT) (popularly referred to as multicolor CT), used in combination with a gold high-density lipoprotein nanoparticle contrast agent (Au-HDL), for characterization of macrophage burden, calcification, and stenosis of atherosclerotic plaques.
Materials and methods: The local animal care committee approved all animal experiments. A preclinical spectral CT system in which incident x-rays are divided into six different energy bins was used for multicolor imaging. Au-HDL, an iodine-based contrast agent, and calcium phosphate were imaged in a variety of phantoms. Apolipoprotein E knockout (apo E-KO) mice were used as the model for atherosclerosis. Gold nanoparticles targeted to atherosclerosis (Au-HDL) were intravenously injected at a dose of 500 mg per kilogram of body weight. Iodine-based contrast material was injected 24 hours later, after which the mice were imaged. Wild-type mice were used as controls. Macrophage targeting by Au-HDL was further evaluated by using transmission electron microscopy and confocal microscopy of aorta sections.
Results: Multicolor CT enabled differentiation of Au-HDL, iodine-based contrast material, and calcium phosphate in the phantoms. Accumulations of Au-HDL were detected in the aortas of the apo E-KO mice, while the iodine-based contrast agent and the calcium-rich tissue could also be detected and thus facilitated visualization of the vasculature and bones (skeleton), respectively, during a single scanning examination. Microscopy revealed Au-HDL to be primarily localized in the macrophages on the aorta sections; hence, the multicolor CT images provided information about the macrophage burden.
Conclusion: Spectral CT used with carefully chosen contrast agents may yield valuable information about atherosclerotic plaque composition.
(c) RSNA 2010.
Conflict of interest statement
See Materials and Methods for pertinent disclosures.
Figures










Similar articles
-
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.Circ Cardiovasc Imaging. 2013 Mar 1;6(2):285-94. doi: 10.1161/CIRCIMAGING.112.000119. Epub 2013 Jan 24. Circ Cardiovasc Imaging. 2013. PMID: 23349231 Free PMC article.
-
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25. JACC Cardiovasc Imaging. 2016. PMID: 27236528 Free PMC article.
-
Science to practice: can CT be performed for multicolor molecular imaging?Radiology. 2010 Sep;256(3):675-6. doi: 10.1148/radiol.101127. Radiology. 2010. PMID: 20720064
-
In Vivo Molecular K-Edge Imaging of Atherosclerotic Plaque Using Photon-counting CT.Radiology. 2021 Jul;300(1):98-107. doi: 10.1148/radiol.2021203968. Epub 2021 May 4. Radiology. 2021. PMID: 33944628 Free PMC article.
-
High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):169-76. doi: 10.1161/ATVBAHA.108.179275. Epub 2009 Oct 8. Arterioscler Thromb Vasc Biol. 2010. PMID: 19815819 Free PMC article. Review.
Cited by
-
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.Adv Drug Deliv Rev. 2017 Apr;113:141-156. doi: 10.1016/j.addr.2016.09.006. Epub 2016 Sep 15. Adv Drug Deliv Rev. 2017. PMID: 27639317 Free PMC article. Review.
-
Cardiac computed tomography with late contrast enhancement: A review.Heliyon. 2024 Jun 4;10(11):e32436. doi: 10.1016/j.heliyon.2024.e32436. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38933964 Free PMC article. Review.
-
An algorithm for constrained one-step inversion of spectral CT data.Phys Med Biol. 2016 May 21;61(10):3784-818. doi: 10.1088/0031-9155/61/10/3784. Epub 2016 Apr 15. Phys Med Biol. 2016. PMID: 27082489 Free PMC article.
-
Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.Int J Nanomedicine. 2024 Aug 27;19:8831-8846. doi: 10.2147/IJN.S474888. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39220195 Free PMC article. Review.
-
Multicolour imaging with spectral photon-counting CT: a phantom study.Eur Radiol Exp. 2018 Oct 17;2(1):34. doi: 10.1186/s41747-018-0063-4. Eur Radiol Exp. 2018. PMID: 30327898 Free PMC article.
References
-
- Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. I. Circulation 2003;108(14):1664–1672 - PubMed
-
- Falk E. Why do plaques rupture? Circulation 1992;86(6 suppl):III30–III42 - PubMed
-
- Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27(1):15–26 - PubMed
-
- Tang TY, Muller KH, Graves MJ, et al. Iron oxide particles for atheroma imaging. Arterioscler Thromb Vasc Biol 2009;29(7):1001–1008 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials